David Hollander - Insider Trading & Ownership

Entity
Individual
Location
C/O Aerie Pharmaceuticals, Inc., 4301 Emperor Blvd., Suite 400, Durham, North Carolina
Summary
The estimated net worth of David Hollander is at least $1.28 M dollars as of July 3, 2024. David Hollander is the CMO & Global Therapeutics Lead of Revance Therapeutics, Inc. and owns shares of Revance Therapeutics, Inc. (RVNC) stock worth about $813 K. David Hollander is the Chief R&D Officer of AERIE PHARMACEUTICALS INC and owns shares of AERIE PHARMACEUTICALS INC stock worth about $469 K.
All Insider Reports
All Insider Reports

Ownership of David Hollander

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RVNC Revance Therapeutics, Inc. CMO & Global Therapeutics Lead $813 K Feb 27, 2024
AERI AERIE PHARMACEUTICALS INC Chief R&D Officer $469 K Feb 4, 2022
KPRX, KPHMW KIORA PHARMACEUTICALS INC Director Jul 1, 2024

Insider Transactions Reported by David Hollander:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership